4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-030712
EVP, Head of R&D acquired 46,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dupont Jakob EVP, Head of R&D | 2020-05-14 | Grant or award | +46,250 | 46,250 | D | ||
| Derivatives | |||||||
| Dupont Jakob EVP, Head of R&D | 2020-05-14 | Grant or award · Employee Stock Option (Right to Buy) | +277,500 | 277,500 | D | ||
Loading xslF345X03/doc4.xml…